ARTICLE | Clinical News
Actemra tocilizumab: Phase III data
May 1, 2006 7:00 AM UTC
Data from a double-blind, Japanese Phase III trial in 125 patients with previously inadequate responses to methotrexate (MTX) showed that those in the Actemra arm had significantly higher response ra...